Female Genital Schistosomiasis in Migrant Women: A Pilot Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-65
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
This pilot study, "GynoBizh," investigates the frequency and clinical characteristics of female genital schistosomiasis (FGS) among migrant women from sub-Saharan Africa living in non-endemic countries. Schistosomiasis is a significant global parasitic disease, with a high seroprevalence in migrants. The study aims to assess the presence of genital lesions through gynecological examinations, colposcopy, and molecular tests, identifying diagnostic markers and associated health conditions. Fifty participants will be followed over a year to improve understanding and management of FGS in underserved populations.
Eligibility criteria
Qualifiers
Women aged 25 to 65 years
Born in a schistosomiasis-endemic area in sub-Saharan Africa
With a positive serology by Schistosoma spp. Western Blot
Disqualifiers
Refusal to participate in the study
Patient unable to provide consent
Patient under guardianship or trusteeship
Patient who is a virgin at the time of selection
Trial design
Treatments tested in this trial
- Gynecology consultation
- Transvaginal ultrasound
- PCR Schistosoma spp
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov